PALISADE BIO INC (PALI:NASDAQ)
$2.06 0.05 (2.4876%)
Analysed PALISADE BIO INC (PALI:NASDAQ) News Sources
Palisade Bio to Participate in Upcoming Investor Conferences
03-09-2026
yahoo.com
Wolfe Highlights Differentiation Potential in Palisade Bio, Inc. (PALI) Clinical Profile
17-04-2026
yahoo.com
Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis
05-05-2026
yahoo.com
Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108
12-05-2026
yahoo.com
We're Not Worried About Palisade Bio's (NASDAQ:PALI) Cash Burn
15-05-2026
yahoo.com
Palisade Bio (PALI) Reports Q1 2026 Results as R&D Expenses Rise to $6.4M
18-05-2026
yahoo.com
Palisade Bio to Participate in the Jefferies Global Healthcare Conference
27-05-2026
yahoo.com
Palisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directors
11-06-2026
yahoo.com
PALI Stock Heads For Best Day In Seven Months – What’s Driving Today’s Rally?
29-06-2026
stocktwits.com
Palisade Bio Draws Bullish Call, Lead IBD Drug Advances Toward Phase 2
27-07-2026
yahoo.com
What is the current price of PALISADE BIO INC (PALI:NASDAQ)?
The current price of PALISADE BIO INC (PALI:NASDAQ) is $2.06.
PALISADE BIO INC (PALI:NASDAQ) absolute price change since previous trading day?
The absolute price change of PALISADE BIO INC (PALI:NASDAQ) since the previous trading day is $0.05.
PALISADE BIO INC (PALI:NASDAQ) percentage price change since previous trading day?
The percentage price change of PALISADE BIO INC (PALI:NASDAQ) since the previous trading day is 2.4876%.
What is the most recent average sentiment score for PALISADE BIO INC (PALI:NASDAQ)?
The most recent average sentiment score for PALISADE BIO INC (PALI:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for PALISADE BIO INC (PALI:NASDAQ)?
The most recent sentiment for PALISADE BIO INC (PALI:NASDAQ) is .
SEC-8K** Filing Available For PALISADE BIO INC (PALI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.